Animal pharmaceuticalsAnimal medical devicesFeed and feed additivesReagentsPesticidesIndustrial chemicalsSanitary productsManufacturing of food and its raw materialsSalesImport and export
Names without a link are companies not yet registered in OpenBizGraph
§05
Network
NETWORK
Loading the relationship graph...
Drag to move · click to open
§06
History
38 EVENTS
Founded Yamaguchi 88 Import Store in Yokohama City, Kanagawa Prefecture.
Established Teikoku-sha Food Factory in Minamikoshida Town, Yokohama City.
Established Teikoku-sha Organ Drug Research Institute within the same factory (Teikoku Organ Pharmaceutical, founded).
Founder Yaguchi Hachijūhachi established the Imperial Society Organ Drug Research Institute in Minami-Yoshida-machi, Yokohama City.
Released the first product extracted from pig organs, the male reproductive gland hormone agent 'Spelmatin'.
Released the labor-inducing agent 'Atonin'.
Reorganized as a corporation, becoming 'Teikoku-sha Organ Drug Research Institute Co., Ltd.'.
Reorganized as a corporation: Imperial Society Organ Drug Research Institute Inc.
Established an Iwate Prefecture branch office (later Iwate Factory) in Maikoro Village, Iwate District (now Morioka City) to purchase and extract pregnant mare urine.
Established Meuro Factory in Meuro Town, Hokkaido to secure stable supply of pregnant mare urine.
Renamed to 'Teikoku Organ Pharmaceutical Co., Ltd.'.
Listed shares on the Tokyo Stock Exchange.
Listed on the Tokyo Stock Exchange.
Commenced manufacturing and sales of animal pharmaceuticals.
Released animal Sinahorin, animal OvaHormone Benzart, and veterinary Serotonin.
Merged with Grelan Pharmaceutical Co., Ltd. and renamed the company to Asuka Pharmaceutical Co., Ltd.
Established the Animal Drugs Section within the Sales Department Expansion Division.
Released seven hormone preparations for animal pharmaceuticals.
Established the Animal Drugs Department.
Entered a sales partnership for the GnRH preparation 'Consellar Injection' (Takeda Pharmaceutical).
Cooperated in sales of the prostaglandin preparation 'Pronalgon F' (Upjohn & Takeda Pharmaceutical).
Reclassified to the First Section of the Tokyo Stock Exchange.
Renamed to the Animal Health Division and began in-house sales.
Merged with Grelan Pharmaceutical Co., Ltd. and renamed the company to Asuka Pharmaceutical Co., Ltd.
Following the transfer of animal-related business from Kyowa Fermentation Bio Co., Ltd., established the Animal Health Business Division.
Established the Animal Health Business Headquarters (Headquarters: Nishi-Shinjuku, Shinjuku-ku, Tokyo) following the transfer of animal-related businesses from Kyowa Hakko Bio Co., Ltd.
Located the headquarters in Nishi-Shinjuku, Shinjuku-ku, Tokyo (Shinjuku Nomura Building).
Established Asuka Animal Health Co., Ltd.
Established Asuka Animal Health Co., Ltd.
Asuka Animal Health Co., Ltd. took over the animal health business of Asuka Pharmaceutical Co., Ltd. and commenced operations.
Asuka Animal Health Co., Ltd. inherited the animal health business of Asuka Pharmaceutical Co., Ltd.
Euglena-Enriched Feed Positively Influences Growth and Feed Efficiency in Weaned Pigs
Miyazaki University, Euglena Co., and Asuka Animal Health Co. confirmed through trials at Miyazaki University that Euglena-enriched feed may positively affect immune-related indicators in weaned pigs. Daily weight gain during the trial period showed a higher trend, and overall feed requirement rate was better than the control group. Some of the research findings were presented orally at the 134th Annual Meeting of the Japanese Society of Animal Science.
Co-Promotion Agreement for Veterinary Medicines for Livestock
DS Pharma Animal Health and ASKA Animal Health have entered into a co-promotion agreement covering 11 veterinary medicine products in the livestock sector. ASKA Animal Health will begin promotional activities on April 1 targeting existing users covered by the agreement, while DS Pharma Animal Health will continue to sell the products.
Notice Regarding Assignment of Duties to Executive Officers
Asuka Animal Health announced that it had decided on the duties of its officers effective June 28, 2018. Representative Director and President Masayuki Matsuba oversees the entire company, while Director Minehiro Okegawa is responsible for development, regulatory affairs, and administration. The other two directors and the auditor serve on a part-time basis.
Changes in Executive Officers and Assignment of Responsibilities
Executive appointments and assigned responsibilities effective June 27, 2023, were decided at the annual general meeting of shareholders and a meeting of the board of directors. Minehiro Okegawa was promoted to Senior Managing Director and will oversee support for the president, development and regulatory affairs, and administration. Fumitoyo Yamaguchi is Representative Director and President, Masahiko Tamura is a director, and Ikuo Kumano is an auditor.
Notice of Executive Transfers and Delegation of Duties
Asuka Animal Health Co., Ltd. decided on executive appointments and duties as of June 25, 2024. Mr. Yūichirō Fukui was newly appointed as a statutory auditor, and former statutory auditor Ikio Kumano resigned on the same date.
Exhibiting at the Japan ET Training Seminar and Embryo Transfer Technology Research Meeting
Asuka Animal Health exhibited at the 16th Japan ET Practitioners Network Training Seminar and the 8th Japan Embryo Transfer Technology Research Meeting. In addition to displaying products, the company supported practical sessions and event operations at the seminar and gave a general presentation at the research meeting. The company says it will apply the insights gained to its future activities.
Changes to Executive Officers and Assignment of Duties
Executive personnel changes effective June 24, 2025, have been decided. Kazuhiro Chiku was newly appointed as an auditor, and former auditor Yuichiro Fukui retired on the same date.
Announcement: Asuka ET Seminar 2025 Okinawa
The Asuka ET Seminar 2025 Okinawa, covering practical aspects of ET, will be held over two days, September 30 and October 1, 2025. The seminar will feature classroom lectures and hands-on training, led by Dr. Hironori Yamamoto, director of Yamamoto Animal ET Clinic. It is intended for people involved in cattle farming. Participation is free, and advance registration is required by September 25.
Announces a Free Webinar on Cushing’s Syndrome
Aska Animal Health Co., Ltd. is offering a free webinar on Cushing’s syndrome in dogs, featuring Toshinori Sako, Professor Emeritus at Nippon Veterinary and Life Science University. The webinar will focus on managing mild and subclinical cases, and cover diagnosis, decisions on when to start treatment, dosing regimens, and explaining the condition to pet owners. The webinar will be available from October 16 to 31, 2025, and requires advance registration.
Asuka ET Seminar 2026 to Be Held at Mount Fuji
A two-day seminar covering the fundamentals and applications of ET practice through lectures and hands-on training will be held on October 27 and 28, 2026, at the Fuji Farm of the Faculty of Agriculture, Tokyo University of Agriculture. Participation is free. Applications will be accepted from September 1 through October 13, with spaces limited to the first 40 applicants.
§08
Public records
GOV
National Tax Agency basic information5011101066957
Source: National Tax Agency Corporate Number Publication Site, basic three items
Trade name
あすかアニマルヘルス株式会社
Trade name (kana)
アスカアニマルヘルス
Name in English
Corporation type
301
Address
〒108-0023 東京都港区芝浦２丁目５番１号
Postal code
1080023
Prefecture code
13
City code
103
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2023-04-04
Change date
2023-04-03
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
12
Correction type
0
Trade name image ID
Address image ID
Sequence number
1952277
METI gBizINFO5011101066957
Source: gBizINFO (Ministry of Economy, Trade and Industry)
